ICAP

ICAP
Name	ICAP
Type	International non-profit / public health institute
Founded	2003
Headquarters	Columbia University Mailman School of Public Health, New York City
Key people	Wafaa El-Sadr; Sten H. Vermund
Focus	HIV/AIDS, tuberculosis, maternal and child health, health systems strengthening

ICAP

ICAP is an international public health organization based in New York that supports large-scale HIV/AIDS, tuberculosis, and maternal and child health programs in low- and middle-income countries. It provides technical assistance, implementation support, monitoring and evaluation, and capacity building for Ministries of Health and global health agencies. ICAP works with a wide range of partners to translate research into practice and to strengthen health systems across Africa, Asia, and the Americas.

Overview

ICAP operates from an academic center and partners with national programs such as Ministry of Health (Mozambique), Ministry of Health and Family Welfare (India), Ministry of Health (South Africa), and Ministry of Health (Uganda). It collaborates with international agencies including World Health Organization, UNAIDS, United States Agency for International Development, Centers for Disease Control and Prevention and foundations like Bill & Melinda Gates Foundation and The Global Fund. ICAP’s activities encompass clinical service delivery, laboratory strengthening, health workforce training, data systems, and policy support with links to implementation science at institutions such as Columbia University Mailman School of Public Health, Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, and London School of Hygiene & Tropical Medicine.

History

ICAP was established in the early 2000s amid a global scale-up of HIV treatment linked to initiatives such as President's Emergency Plan for AIDS Relief and the expansion of antiretroviral therapy. Early collaborations included national programs in Nigeria, Kenya, and Zambia and partnerships with research networks like HIV Prevention Trials Network and International AIDS Society. Over time ICAP extended its remit to integrate tuberculosis programs tied to Stop TB Partnership efforts, maternal and child health aligned with UNICEF priorities, and to participate in multicountry evaluations comparable to work by Médecins Sans Frontières and Partners In Health.

Structure and Governance

ICAP is organized within an academic public health department and governed through advisory boards drawing experts from institutions such as Columbia University, Harvard University, Yale University, University of Cape Town, and Makerere University. Senior leadership historically includes clinicians and epidemiologists associated with awards and memberships like the MacArthur Fellows Program and societies such as the Infectious Diseases Society of America. Its governance interfaces with funders including PEPFAR, Global Fund to Fight AIDS, Tuberculosis and Malaria, and bilateral donors, while operational units mirror divisions found in global health NGOs like Clinton Health Access Initiative and Elizabeth Glaser Pediatric AIDS Foundation.

Programs and Initiatives

ICAP implements programs in HIV testing and treatment, tuberculosis screening and management, prevention of mother-to-child transmission linked to protocols from WHO and UNAIDS, and adolescent health interventions similar to initiatives by UNFPA. It supports laboratory networks modeled after African Society for Laboratory Medicine guidance, and health information systems interoperable with platforms like those used by DHIS2 projects. Capacity-building initiatives draw on training approaches used by London School of Hygiene & Tropical Medicine and programmatic tools used by Centers for Disease Control and Prevention technical assistance teams. ICAP has participated in implementation science collaborations with trials and cohorts from Partners PrEP Trial-type research and regional consortia including East, Central and Southern Africa Health Community.

Funding and Partnerships

Major funding streams for ICAP have originated from multilateral and bilateral sources such as United States Agency for International Development, PEPFAR, The Global Fund, and philanthropic donors including Bill & Melinda Gates Foundation and Gilead Sciences programs. Partnerships include national Ministries of Health in countries like Ethiopia, Tanzania, Mozambique, and Malawi; academic partners such as Columbia University and Johns Hopkins University; and implementing partners such as Jhpiego and ICRC-adjacent collaborations. Grant management and program delivery practices reflect standards used by UNAIDS and reporting frameworks akin to those required by PEPFAR and Global Fund grants.

Impact and Criticism

ICAP reports contributions to expanded antiretroviral therapy coverage, strengthened laboratory capacity, and improved maternal and child health indicators in partner countries comparable to impacts documented by PEPFAR and Global Fund-supported programs. External evaluations have noted measurable increases in testing, linkage to care, and retention similar to results from Partners In Health and Médecins Sans Frontières programs. Criticisms mirror broader debates about international implementers: concerns about sustainability and government ownership echoed in reviews of bilateral aid initiatives, issues of data sovereignty raised in discussions involving World Health Organization guidance, and tensions between rapid scale-up and local capacity emphasized by observers of global health scale-up efforts. Independent assessments and peer-reviewed studies in journals like The Lancet and PLOS Medicine have analyzed ICAP-supported program outcomes alongside comparable global health initiatives.

Category:Global health organizations